SummaryAvalere research was published online in the Journal of Clinical Oncology Clinical Cancer Informatics, showing a considerable drop in cancer screening, diagnosis, and treatment for Medicare beneficiaries as a result of the ongoing COVID-19 pandemic.
The study, conducted in collaboration with the Community Oncology Alliance (COA), utilized Inovalon Provider Clearinghouse data, which represents 5%–7% of the Medicare fee-for-service (FFS) population. The goal of the analysis was to examine over 6 million oncology claims to identify changes in the utilization of cancer care services and gain insight into the impact of COVID-19 on access to cancer care, about those services ability to diagnose and treat cancer in a timely manner, and on the treatment journeys for patients.
“The Impact of COVID-19 on Cancer Care: How the Pandemic is Delaying Cancer Diagnosis and Treatment for American Seniors” found reductions in the following areas:
- Patient evaluation and management visits for both new and established patients (Figure 1)
- Breast, colon, prostate, and lung cancer screenings (Figure 2)
- Cancer biopsies and surgeries
- Cancer-related hospitalizations
- Chemotherapy infusions (Figure 3)
Read the COA press release on this research.
To receive Avalere updates, connect with us.
produces measurable results. Let's work together.